Antimicrobial peptides can enhance the risk of persistent infections

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Berditsch, Marina ^a   Afonin, Sergii ^a   Vladimirova, Tatiana ^a   Wadhwani, Parvesh ^a   Ulrich, Anne S ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874195248     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00222     Document Type: Article

References (41)

1. Afonin, S., Durr, U. H. N., Wadhwani, P., Salgado, J., and Ulrich, A. S. (2008a). Solid state NMR structure analysis of the antimicrobial peptide gramicidin S in lipid membranes: concentration-dependent re-alignment and self-assembly as a beta-barrel. Top. Curr. Chem. 273, 139-154.
2. Afonin, S., Grage, S. L., Ieronimo, M., Wadhwani, P., and Ulrich, A. S. (2008b). Temperature-dependent trans-membrane insertion of the amphiphilic peptide PGLa in lipid bilayers observed by solid state 19F NMR spectroscopy. J. Am. Chem. Soc. 130, 16512-16514.
3. Batheja, P., Sheihet, L., Kohn, J., Singer, A. J., and Michniak-Kohn, B. (2011). Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies. J. Control Release 149, 159-167.
4. Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250.
5. Bürck, J., Roth, S., Wadhwani, P., Afonin, S., Kanithasen, N., Strandberg, E., and Ulrich, A. S. (2008). Conformation and membrane orientation of amphi-philic helical peptides by oriented circular dichroism. Biophys. J. 95, 3872-3881.
6. Dorr, T., Vulic, M., and Lewis, K. (2010). Ciprofoxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8, e1000317. doi: 10.1371/journal.pbio.1000317
7. Epand, R. M., and Vogel, H. J. (1999). Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462, 11-28.
8. Falagas, M. E., Rafailidis, P. I., and Matthaiou, D. K. (2010). Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist. Updat. 13, 132-138.
9. Fjell, C. D., Hiss, J. A., Hancock, R. E. W., and Schneider, G. (2012). Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11, 37-51.
10. Fux, C. A., Costerton, J. W., Stewart, P. S., and Stoodley, P. (2005). Survival strategies of infectious bioflms. Trends Microbiol. 13, 34-40.
11. Giuliani, A., Pirri, G., and Nicoletto, S. F. (2007). Antimicrobial peptides: an overview of a promising class of therapeutics. Cent. Eur. J. Biol. 2, 1-33.
12. Glaser, R. W., Sachse, C., Durr, U. H., Wadhwani, P., Afonin, S., Strandberg, E., and Ulrich, A. S. (2005). Concentration-dependent realignment of the antimicrobial peptide PGLa in lipid membranes observed by solid-state 19F-NMR. Biophys. J. 88, 3392-3397.
13. Hancock, R. E., Nijnik, A., and Philpott, D. J. (2012). Mo dulating immunit y as a therapy for bacter ial infections. Nat. Rev. Microbiol. 10, 243-254.
14. Hartmann, M., Berditsch, M., Hawecker, J., Ardakani, M. F., Gerthsen, D., and Ulrich, A. S. (2010). Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob. Agents Chemother. 54, 3132-3142.
15. Ieronimo, M., Afonin, S., Koch, K., Berditsch, M., Wadhwani, P., and Ulrich, A. S. (2010). 19F NMR analysis of the antimicrobial peptide PGLa bound to native cell membranes from bacterial protoplasts and human erythrocytes. J. Am. Chem. Soc. 132, 8822-8824.
16. Kaplan, J. B. (2011). Antibiotic-induced bioflm formation. Int. J. Artif. Organs 34, 737-751.
17. Kohanski, M. A., Depristo, M. A., and Collins, J. J. (2010). Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol. Cell 37, 311-320.
18. Krauss, E. M., and Chan, S. I. (1983). Complexation and phase transfer of nucleotides by gramicidin S. Biochemistry 22, 4280-4291.
19. Lewis, K. (2010). Persister cells. Annu. Rev. Microbiol. 64, 357-372.
20. Matsuzaki, K. (1998). Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1376, 391-400.
21. Matsuzaki, K., Mitani, Y., Akada, K. Y., Murase, O., Yoneyama, S., Zasloff, M., and Miyajima, K. (1998). Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry 37, 15144-15153.
22. Mogi, T., and Kita, K. (2009). Gramicidin S and polymyx-ins: the revival of cationic cyclic peptide antibiotics. Cell. Mol. Life Sci. 66, 3821-3826.
23. Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., and Bienert, M. (1998). Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414, 127-139.
24. Oliver, J. D. (2005). The viable but nonculturable state in bacteria. J. Microbiol. 43, 93-100.
25. Otto, M. (2009). Bacterial sensing of antimicrobial pep-tides. Contrib. Microbiol. 16, 136-149.
26. Palm, C., Netzereab, S., and Hallbrink, M. (2006). Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 27, 1710-1716.
27. Peschel, A. (2002). How do bacteria resist human ant ibac-terial peptides? Trends Microbiol. 10, 179-186.
28. Proctor, R. A., Von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., and Peters, G. (2006). Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4, 295-305.
29. Radek, K., and Gallo, R. (2007). Antimicrobial peptides: natural effectors of the innate immune system. Semin. Immunopathol. 29, 27-43.
30. Spindler, E. C., Hale, J. D., Giddings, T. H. Jr., Hancock, R. E., and Gill, R. T. (2011). Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c. Antimicrob. Agents Chemother. 55, 1706-1716.
31. Stewart, P. S., and Costerton, J. W. (2001). Antibiotic resistance of bacteria in bioflms. Lancet 358, 135-138.
32. Strandberg, E., Tremouilhac, P., Wadhwani, P., and Ulrich, A. S. (2009). Synergistic transmembrane insertion of the heterodimeric PGLa/magainin 2 complex studied by solid-state NMR. Biochim. Biophys. Acta 1788, 1667-1679.
33. Unoson, C., and Wagner, E. G. (2008). A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol. Microbiol. 70, 258-270.
34. von Eiff, C., Perets, G., and Becker, K. (2006). The small colony variants (SCV) concept-the role of staphylococcal SCVs in persistent infections. Injury 37, S26-S33.
35. Wellinghausen, N., Chatterjee, I., Berger, A., Niederfuehr, A., Proctor, R. A., and Kahl, B. C. (2009). Characterization of clinical Enterococcus faecalis small-colony variants. J. Clin. Microbiol. 47, 2802-2811.
36. Westerhoff, H. V., Zasloff, M., Rosner, J. L., Hendler, R. W., De Waal, A., Vaz Gomes, A., Jongsma, P. M., Riethorst, A., and Juretic, D. (1995). Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes. Eur. J. Biochem. 228, 257-264.
37. Zaiou, M. (2007). Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J. Mol. Med. 85, 317-329.
38. Zhanel, G. G., and Nicolle, L. E. (1992). Effect of subin-hibitory antimicrobial concentrations (sub-MICs) on in-vitro bacterial adherence to uroepithelial cells. J. Antimicrob. Chemother. 29, 617-627.
39. Zhang, L., Dhillon, P., Yan, H., Farmer, S., and Hancock, R. E. (2000). Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 3317-3321.
40. Zhang, L., Rozek, A., and Hancock, R. E. (2001). Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 276, 35714-35722.
41. Zhao, D., and Dhalla, N. S. (1991). Pur ifcat ion and composition of Ca2+/Mg2+ ATPase from rat heart plasma membrane. Mol. Cell. Biochem. 107, 135-149.